Meet a Pioneer Advancing Psilocybin-Assisted Psychotherapy
Psychedelic therapies are quickly becoming part of the mainstream conversation as many states move to legalize the use of psilocybin and clinical studies continue producing promising results. Now, a medical company creating an ecosystem of solutions centred on the research, development, and delivery of safe, evidence-based, accessible psychedelic-assisted psychotherapies is one operation that could stand to benefit the most from its legalization. Stockhouse's Jon Brown reports.
1 | Top Story: An Australian start-up to benefit from new CBD E.U. ruling; secures high-profile cannabis executive Bruce Linton as the business gets set for stellar growth into 2021.
2 | Field Trip Health Ltd. boosts access to psychedelic therapies and investing options.
3 | CannTrust Holdings Inc. back in business to sell legal cannabis again.
4 | Delta 9 Cannabis Inc. announces a $5 million upsize to bought short form prospectus.
5 | Aurora Cannabis strikes medical cannabis supply deal with Israel's Cantek Holdings.
Top Cannabis Stocks - Nov 26 to Dec 2, 2020
1. T.APH | 91,788 views | Aphria Inc.
2. T.HEXO | 40,492 views | HEXO Corp.
3. T.WEED | 32,918 views | Canopy Corp.
4. T.ACB | 23,922 views | Aurora Cannabis Inc.
5. T.AH | 18,254 views | Aleafia Health Inc.
6. C.TNY | 16,008 views | Tinley Beverage Co Inc.
FULL DISCLOSURE: Numinus Wellness Inc. and Field Trip Health are clients of Stockhouse Publishing.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.